Zobrazeno 1 - 6
of 6
pro vyhledávání: '"David Michael Gill"'
Autor:
Ramya Thota, Megan Mullalley, David Michael Gill, Kimberlee Rowett, Zachary Reese, Derrick S. Haslem
Publikováno v:
Journal of Clinical Oncology. 40:142-142
142 Background: We previously reported the safety and feasibility of tele-chemotherapy with remote administration of chemotherapy (chemo) in rural hospitals using experienced chemo nurses with direct supervision from medical oncologist at a tertiary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02d854f1ce3c0cb3616dd2057efa9d13
https://doi.org/10.1200/jco.2022.40.28_suppl.142
https://doi.org/10.1200/jco.2022.40.28_suppl.142
Autor:
Christopher R. Weil, Ryan J. Hutten, Brandon M. Barney, Angela Fagerlin, David K. Gaffney, David Michael Gill, Gary Whipple, Terence Duane Rhodes, Laura Scherer, Gita Suneja, Jonathan David Tward, Theresa Louise Werner, Skyler B Johnson, Jaden D. Evans
Publikováno v:
Journal of Clinical Oncology. 40:e24130-e24130
e24130 Background: Complementary and alternative medicine (CAM) use has been associated with worse survival outcomes in cancer patients compared to standard of care therapies. CAM has received a significant increase in public awareness and interest i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29ffaf9c0cbc9979c57dd0bc80a8dd7f
https://doi.org/10.1200/jco.2022.40.16_suppl.e24130
https://doi.org/10.1200/jco.2022.40.16_suppl.e24130
Autor:
Ryan J. Hutten, Christopher R. Weil, Brandon M. Barney, Angela Fagerlin, David K. Gaffney, David Michael Gill, Gary Whipple, Terence Duane Rhodes, Laura Scherer, Gita Suneja, Jonathan David Tward, Theresa Louise Werner, Jaden Evans, Skyler B Johnson
Publikováno v:
Journal of Clinical Oncology. 40:e18739-e18739
e18739 Background: Compared to standard of care treatments, complementary and alternative medicine (CAM) use has been associated with decreased survival in cancer patients. CAM includes a broad range of treatments including vitamins/minerals, herbs/s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1955a7b5020232b09bc23123890972c
https://doi.org/10.1200/jco.2022.40.16_suppl.e18739
https://doi.org/10.1200/jco.2022.40.16_suppl.e18739
Autor:
Emily Moody, McCall Larson, Samantha Greenberg, Taylor Jump, Mckenzie Bell, Jesse Gygi, Lisa Garcia, Desiree Dougherty, Brock O Neil, Steven C Lynch, Derrick S. Haslem, David Michael Gill
Publikováno v:
Journal of Clinical Oncology. 40:59-59
59 Background: Guidelines recommend germline genetic not only for men with advanced and metastatic prostate cancer but also those with NCCN-high risk disease. Many men harboring germline DNA repair defects would not have met criteria for testing unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42421985dd98c51803f87354f2200042
https://doi.org/10.1200/jco.2022.40.6_suppl.059
https://doi.org/10.1200/jco.2022.40.6_suppl.059
Autor:
David Michael Gill, David Gaston, Andrew W. Hahn, Erin B. Bailey, Tyler Howard Buckley, Eric Johnson, Julia A. Batten, Anitha Alex, Kenneth M. Boucher, David D. Stenehjem, Neeraj Agarwal
Publikováno v:
Journal of Clinical Oncology. 35:261-261
261 Background: AA is approved for Mcrpc with co-administration with P to prevent MCE toxicity such as hypertension, hypokalemia and edema. However, use of P is often not desirable by the relatively asymptomatic patients because of potential for detr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47c6a5f8d80ac2d8ce2d28cf54b7f928
https://doi.org/10.1200/jco.2017.35.6_suppl.261
https://doi.org/10.1200/jco.2017.35.6_suppl.261
Autor:
Anitha Alex, David D. Stenehjem, Przemyslaw Twardowski, Heather H. Cheng, David Michael Gill, Tyler Howard Buckley, Shiven B. Patel, Elizabeth Riley Kessler, Namita Chittoria, Aarati Poudel, Ulka N. Vaishampayan, Neeraj Agarwal
Publikováno v:
Journal of Clinical Oncology. 34:5083-5083
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01fd0c2a8ede088701665bd326c67fcf
https://doi.org/10.1200/jco.2016.34.15_suppl.5083
https://doi.org/10.1200/jco.2016.34.15_suppl.5083